INTANGIBLE ASSETS, NET

12 Months Ended

Mar. 31, 2014

NOTE 7. INTANGIBLE ASSETS, NET

Intangible assets, net, at March 31, 2014 and 2013 consisted of the following (in thousands):

	Cost		Accumulated Amortization		Net Book Value
Balance, March 31, 2014
Licenses	$	5,000	$	3,800		1,200
Other		637		213		424
Total intangible assets	$	5,637	$	4,013	$	1,624

Balance, March 31, 2013
Licenses	$	5,000	$	2,360		2,640
Other		637		155		482
Total intangible assets	$	5,637	$	2,515	$	3,122

In January 2009, we entered into a license agreement with Inverness Medical Switzerland GmbH, now known as Alere Switzerland GmbH (“Alere”), pursuant to which we licensed co-exclusively certain worldwide patent rights. We paid a $5.0 million up-front license fee to Alere in January 2009, which was recorded as an intangible asset on the consolidated balance sheets. See Note 10, “Commitments and Contingencies” for additional information on our patent license agreement with Alere.

Other intangible assets, with a cost basis of $249,000 and $388,000, were acquired by issuing warrants to Kansas State University Institute for Commercialization (formerly known as National Institute for Strategic Technology Acquisition and Commercialization) in January 2011 and October 2011, respectively.

Amortization expense for intangible assets, included in cost of revenues or in the respective operating expense line based on the function and purpose for which it is being used, amounted to $1.5 million, $868,000 and $614,000 in fiscal 2014, 2013 and 2012, respectively. Based on our intangible assets subject to amortization as of March 31, 2014, the estimated amortization expense for succeeding years is as follows (in thousands):

	Estimated Future Annual Amortization Expense
			Fiscal Year Ending March 31,
	Total		2015		2016		2017		2018		2019		Thereafter
Amortization expense	$	1,624	$	1,258	$	58	$	58	$	58	$	58	$	134